395 W 12th Ave
Columbus, OH 43210
Phone: (614) 293-4997
Assistant Professor-Clinical, Nephrology
Enclosed with this narrative is supporting documentation for my application for promotion from Assistant Professor to Associate Professor on the Clinical Track. The enclosed documentation deals primarily with the time since my initial appointment at The Ohio State University Medical Center on the Clinical Track in September 2006. However, it also includes information regarding my clinical training at The Ohio State University. It also describes my basic science work following my appointment as an Assistant Professor on the Tenure Track in July 2002. When the mentor of my NIH sponsored K-award took the position as Nephrology Division Director at the University of Florida Jacksonville, I was recruited and subsequently joined him. It was there that my research interest shifted from basic science to clinical research. I also became very active in the medical education program there.
I returned to the Division of Nephrology at The Ohio State University Medical Center in 2006 to pursue formal training in clinical research in the College of Public Health. I was also given the opportunity to expand my growing interest in medical education. Since my return, I have been fortunate to be active in the educational, clinical, and research arenas. In the educational arena, after serving as the Assistant Renal Module Leader for 4 years, I have served as Leader of the Renal Module for the last 4 years. I spearheaded efforts to incorporate team based learning concepts into the curriculum. In the last year, I incorporated E-learning methods into the module while creating “Consult Rounds” sessions to provide clinical applications of foundational knowledge. These have been met with very positive reviews from students. I was fortunate to receive the teaching award for the Renal Module in 2009 and 2010. At the College level, I was given the Faculty Courage to Teach Award in April 2014. In the research field, I completed work on my Masters of Public Health in 2010. I am currently the site PI for the NIH-sponsored, multicenter Systolic Blood Pressure Intervention Trial (SPRINT). I have led all aspects of the trial in our Division. We were fortunate to receive awards for CKD recruitment, study retention, and achievement of study targets in 2014. I was also appointed to serve on the national Morbidity and Mortality Subcommittee, where I have been involved in adjudicating over 300 outcomes individually, in pairs, and in committee. I have co-authored 15 manuscripts and numerous abstracts. I have also been very active clinically during this time. I was fortunate to have the highest UltraCare Score (a multifaceted clinical outcomes score for dialysis patients who receive dialysis from Fresenius Medical Corporation) in the Western Ohio region in August 2010. I have also been recognized twice by the Department for outstanding Patient Satisfaction Scores and have received 9 Bravos from patients and staff for exemplary patient care in the last 4 years.
Taken together, I feel that my work supports my application for promotion to Associate Professor on the Clinical Track. Thank you for your time and attention to this application.
|1997 - present||Medical Doctor: State Medical Board of Ohio|
|2003 - present||Board Certification: American Board of Internal Medicine|
|2014 - present||Board Certification: American Board of Internal Medicine|
|09/01/2006||Nephrology inpatient and outpatient (The Ohio State University Medical Center)|
Jopling M, Balch D, Howie M, Bhatt UY, Dzonczyk R. "Early Diagnosis of Cardiac Tamponade By Time Averaged CVP Waveform Analysis." In Anesthesiology. (September 1993). A489-.
Bhatt U, Haller L, Nahman Jr., N.S., Hebert L, Bay W. "An Examination of the Correlation Between Urea-Reduction Ratio and Total Plasma Homocysteine." In Journal of the American Society of Nephrology. (November 1999). A1654-.
Bhatt UY, Plott DT, Fu J, Nahman NS Jr, Rovin BH. "Bone marrow engraftment and acute renal failure." In Journal of the American Society of Nephrology. (October 2000). A2707-.
Sas J, Johnson A, Williams C, Bhatt UY, Shirey KG, Sferra TJ, Nahman NS Jr. "Inhibition of TGF mRNA with a decorin transgene: Implications for gene therapy of diabetic nephropathy." In Journal of Investigative Medicine. (April 2001). 305A-.
Johnson AB, Wick MP, Bhatt UY, Williams C, Sas J, Shie S, Jewell S, Sferra TJ, Nahman Jr., NS. "Adenoviral-microsphere complexes for glomerular gene delivery: Potential ischemic and inflammatory events following microparticle embolization." In Molecular Therapy. (June 2001). S340-.
Bhatt UY, McKeegan C, Urban K, Dakappagari N, Johnson A, Williams C, Sas J, Ellison J, Kaumaya PT, Jewell S, Sferra TJ, Nahman Jr., NS. "Distribution of the Coxsackie-Adenovirus receptor protein in the human kidney." In Molecular Therapy. (June 2001). S336-.
Bhatt UY, Johnson A, Williams C, Sas J, Sferra TJ, Nahman NS Jr. "Induction of a coxsackie-adenovirus receptor transgene increases adenoviral transduction efficiency." In Journal of the American Society of Nephrology. (October 2001). 672A-.
Bringardner AB, Bhatt UY, Sferra TJ, Wick MP, Nahman NS, Jr. "GeneChip analysis of rat kidney following microparticle injection or renal artery cross-clamp: Insights for arterial delivery of glomerular DNA-microparticle complexes." In Journal of Investigative Medicine. (September 2002). 224A-.
Bhatt UY, Shen N, Ellison JS, Bringardner AB, Sferra TJ, Nahman NS, Jr. "Angiotensin II-Mediated effects on adenoviral gene delivery in human mesangial cells." In Journal of the American Society of Nephrology. (September 2002). 128A-.
Bringardner,A,B; Bhatt,U,Y; Sferra,T,J; Wick,M,P; Nahman,N,S. "Gene expression profiling of the ischemic rat kidney.." In JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. (September 2002). 143A-143A.
Nahman,N,S; Bringardner,A; Bhatt,U,Y; Sferra,T,J; Husa,M; Verrill,T; Vaughn,J. "Gene therapy with decorin reduces diabetic organomegaly in rats." In MOLECULAR THERAPY. (May 2003). S399-S399.
Bhatt,U,Y; Shen,N,S; Bringardner,A,B; Husa,M; Sferra,T,J; Nahman,N,S. "Early gene expression signatures in human mesangial cells following adenoviral transduction." In MOLECULAR THERAPY. (May 2003). S144-S144.
Nahman,N,S; Bringardner,A; Bhatt,U,Y; Sferra,T,J. "Assessing the safety of microparticle-based glomerular gene delivery using a class comparison of DNA microarrays from ischemic or microparticle-injected kidneys.." In JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. (November 2003). 372A-372A.
Bhatt,U,Y; Smith,A,N; Bringardner,A,B; Vaughn,J; Verrill,T; Sferra,T,J. "Effect of adenoviral transduction on mesangial cell gene expression.." In JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. (November 2003). 371A-371A.
Bringardner,A; Bhatt,U,Y; Sferra,T,J; Wick,M; Husa,M; Ellison,J; Mansfield,A; Nahman,N,S. "Kidney gene expression signatures following aortic injection of microspheres versus frank renal ischemia: Implications for microparticle-based glomerular gene delivery systems." In MOLECULAR THERAPY. (May 2003). S307-S307.
Hostetler T, Hixon-Vermillion B, Plott D, Bhatt UY. "Changes in hemodynamics associated with duration of CRRT." In Journal of the American Society of Nephrology. (October 2004). 191A-.
Bhatt UY, Smith AN, Bringardner AB, Sferra TJ, Nahman, Jr. NS. "Regulation of cellular CAR expression and adenoviral transduction." In Journal of the American Society of Nephrology. (October 2004). 424A-.
Bhatt UY, Smith AN, Bringardner AB, Sferra TJ, Nahman, Jr. NS. "Glucose mediated alterations in cellular CAR expression." In Journal of the American Society of Nephrology. (October 2004). 424A-.
Plott DT, Yamokoski T, Sparks J, Bhatt UY. "Survival and renal recovery in ICU patients receiving CRRT." In Blood Purification. (March 2004). 231-.
Plott D, Hostetler T, Hixon-Vermillion B, Bhatt UY. "Hemodynamic effects of variable replacement fluid rates in hemodiafiltration." In Blood Purification. (March 2005). 171-.
Hostetler T, Plott D, Hixon-Vermillion B, Bhatt UY. "Effect of Illness Severity Scores on Hemodynamic Impact of CRRT." In Blood Purification. (March 2005). 170-.
Plott D, Birmingham D, Rovin B, Hebert L, Bhatt UY. "Association of Air Quality Index and Renal Flares of Systemic Lupus Erythematosus." In Journal of the American Society of Nephrology. (November 2007). TH-PO1074.
Udayan Y. Bhatt, Robert D. Toto, Shona Methven, et al.. "The Nephropathy of the Patients in the African American Study of Kidney." In Journal of the American Society of Nephrology. (November 2013). 157A-.
|1991||B.S., The Ohio State University|
|1995||M.D., The Ohio State University|
|2010||M.Public Hlth., The Ohio State University|
|2013 - present||International Journal of Nephrology|
|2013 - present||Circulation|
|2005 - present||Fellow of the American Society of Nephrology. American Society of Nephrology.|
|2009 - present||College of Medicine Teaching Award. College of Medicine.|
|2010 - present||College of Medcine Teaching Award. College of Medicine.|
|2014 - present||Courage to Teach Award. College of Medicine.|
Nahman Jr, NS, Drost WT, Bhatt UY, Sferra TJ, Johnson A, Gamboa P, Hinkle GH, Haynam A, Bergdall V, Hickey C, Bonagura JD, Brannon-Peppas L, Ellison JS, Mandfield A, Shie S, Shen N. "Biodegradable microparticles for in vivo glomerular targeting." Biomed MicroDevelopment. Vol. 4(3), (January 2002.): 189-195.
Bhatt,Udayan,Y; Sferra,Thomas,J; Johnson,Amy; Williams,Caroline; Shirey,Kristen; Venema,Tammy; Nuovo,Gerard,J; Nahman,N,Stanley. "Glomerular beta-galactosidase expression following transduction with microsphere-adenoviral complexes.." Kidney international. Vol. 61, no. 1. (January 2002.): S68-72.
Bringardner AB, Bhatt UY, Sferra TJ, Wick MP, Nahman NS, Jr.. "Kidney gene expression signatures following microparticle injection: Implications for arterial delivery of DNA-particle complexes." J of Vasc Res. Vol. 39, (January 2002.): S33-.
Roy, Sashwati; Clark, Clancy, J; Mohebali, Khashayar; Bhatt, Udayan; Wallace, William, A; Nahman, N Stanley; Ellison, E Christopher; Melvin, W Scott; Sen, Chandan K. "Reactive oxygen species and EGR-1 gene expression in surgical postoperative peritoneal adhesions.." World Journal of Surgery. Vol. 28, no. 3. (January 2004.): 316-20.
McLaughlin NG, Bhatt UY, Cu GA, Mars RL, Nahman, Jr. NS. "A review of the diagnosis and therapy of diabetic nephropathy." NE FL Med. Vol. 56(2), (January 2005.): 27-31.
Alexandraki I, Sullivan R, Zaiden R, Bailey C, McCarter Y, Khan A, Offutt JK, Bhatt UY, Plott D, Nahman NS Jr.. "Blood culture isolates in hemodialysis vascular catheter-related bacteremia." Am J Med Sci. Vol. 4, no. 336. (October 2008.): 297-302.
Brodsky,Sergey,V; Collins,Michael; Park,Edward; Rovin,Brad,H; Satoskar,Anjali,A; Nadasdy,Gyongyi; Wu,Haifeng; Bhatt,Udayan; Nadasdy,Tibor; Hebert,Lee,A. "Warfarin Therapy That Results in an International Normalization Ratio above the Therapeutic Range Is Associated with Accelerated Progression of Chronic Kidney Disease." NEPHRON CLINICAL PRACTICE. Vol. 115, no. 2. (January 2010.): C142-C146.
Brodsky,Sergey,V; Nadasdy,Tibor; Rovin,Brad,H; Satoskar,Anjali,A; Nadasdy,Gyongyi,M; Wu,Haifeng,M; Bhatt,Udayan,Y; Hebert,Lee,A. "Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate." KIDNEY INTERNATIONAL. Vol. 80, no. 2. (July 2011.): 182-190.
Ware,Kyle; Brodsky,Polina; Satoskar,Anjali,A; Nadasdy,Tibor; Nadasdy,Gyongyi; Wu,Haifeng; Rovin,Brad,H; Bhatt,Udayan; Von Visger,Jon; Hebert,Lee,A; Brodsky,Sergey,V. "Warfarin-Related Nephropathy Modeled by Nephron Reduction and Excessive Anticoagulation." JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. Vol. 22, no. 10. (October 2011.): 1856-1862.
Shah,R; Bhatt,U,Y; Van Cleef,S; Farley,M; Davis,A; Swope,M; Agarwal,A,K. "Vascular access thrombosis and interventions in patients missing hemodialysis sessions." CLINICAL NEPHROLOGY. Vol. 76, no. 6. (December 2011.): 435-439.
Hebert,Paul,L; Nori,Uday,S; Bhatt,Udayan,Y; Hebert,Lee,A. "A modest proposal for improving the accuracy of creatinine-based GFR estimating equations." NEPHROLOGY DIALYSIS TRANSPLANTATION. Vol. 26, no. 8. (August 2011.): 2426-U11.
Hirsch,Sheldon; Hirsch,Jackie; Bhatt,Udayan; Rovin,Brad,H. "Tolerating Increases in the Serum Creatinine following Aggressive Treatment of Chronic Kidney Disease, Hypertension and Proteinuria: Pre-Renal Success." AMERICAN JOURNAL OF NEPHROLOGY. Vol. 36, no. 5. (January 2012.): 430-437.
Parikh,Samir; Nijmeh,Ruba; Van Cleef,Sheri; Timmerman,Sue; Bhatt,Udayan,Y; Agarwal,Anil,K. "Catheter Outcomes in the Short-term Inpatient Setting: A Controlled Quality Improvement Study Comparing Citrate and Heparin Lock." SEMINARS IN DIALYSIS. Vol. 25, no. 3. (May 2012.): 351-356.
Singh,Neeraj; Parikh,Samir; Bhatt,Udayan; VonVisger,Jon; Nori,Uday; Hasan,Ayesha; Samavedi,Srinivas; Andreoni,Kenneth; Henry,Mitchell; Pelletier,Ronald; Rajab,Amer; Elkhammas,Elmahdi; Pesavento,Todd. "Cardiac Stress Test as a Risk-Stratification Tool for Posttransplant Cardiac Outcomes in Diabetic Kidney Transplant Recipients." TRANSPLANTATION. Vol. 94, no. 12. (December 2012.): 1224-1229.
Dwyer,Jamie,P; Sika,Mohammed; Schulman,Gerald; Chang,Ingrid,J; Anger,Michael; Smith,Mark; Kaplan,Mark; Zeig,Steven; Koury,Mark,J; Blumenthal,Samuel,S; Lewis,Julia,B. "Dose-Response and Efficacy of Ferric Citrate to Treat Hyperphosphatemia in Hemodialysis Patients: A Short-term Randomized Trial." AMERICAN JOURNAL OF KIDNEY DISEASES. Vol. 61, no. 5. (May 2013.): 759-766.
|September 2002||Bhatt UY, Ellison JS, Shen N, Sferra TJ, Nahman NS, Jr."Angiotensin II down regulates adenoviral transduction via AT1" Chicago.|
|October 2004||Bhatt UY, Hostetler T, Plott D, Hixon-Vermillion B, Nahman, Jr NS."Replacement fluid rates impact hemodynamic parameters in continuuous hemodiafiltration" Gainesville. : 822A|
|October 2005||Bhatt UY, Bringardner AB."Glucose mediates lineage-specific alterations in renal CAR expression" Gainesville. : 805A|
Bhatt, U, Toto, R, et al.. The kidney disorder in the African American study of kidney disease and hypertension manifests low albumin/protein ratios typical of a tubulopathy: Pathophysiologic and clinical implications. January 2014.